14-day Premium Trial Subscription Sign Up For FreeGet Free
Nasdaq - Total Crash or Bounce-Up? Click To Watch.

Intec Pharma Ltd. Stock Forecast

NASDAQ:NTEC Delisted Open a Brokerage Account

$2.05 (0%)

Volume: 0

Closed: Aug 17, 2022

Hollow Logo Score: 0.000

Intec Pharma Ltd. Stock Forecast

$2.05 (0%)

Volume: 0

Closed: Aug 17, 2022

Score Hollow Logo 0.000

Intec Pharma Ltd. Company Profile

12 Hartom Street

Jerusalem 9777512

972 2 586 4657

www.intecpharma.com

Industry: Biotechnology

Sector: Healthcare

Intec Pharma Ltd.

Description

Intec Pharma Ltd., a clinical stage biopharmaceutical company, focuses on developing drugs based on its proprietary Accordion Pill platform technology in Israel. Its Accordion Pill is an oral drug delivery system that is designed to enhance the efficacy and safety of existing drugs and drugs in development by utilizing a gastric retention and specific release mechanism. The company’s lead product candidate is Accordion Pill Carbidopa/Levodopa (AP-CDLD), which has completed Phase II clinical trials for the treatment of Parkinson’s disease symptoms in advanced Parkinson’s disease patients. It is also developing Accordion Pill Zaleplon (AP-ZP) that has completed Phase II clinical trials for the treatment of insomnia, including sleep induction and the improvement of sleep maintenance; and Accordion Pill, which has completed a Phase I clinical trial for the prevention and treatment of gastroduodenal and small bowel Nonsteroidal Anti-Inflammatory Drug induced ulcers. The company was formerly known as Intec Pharmaceuticals (2000) Ltd. and changed its name to Intec Pharma Ltd. in March 2004. Intec Pharma Ltd. was founded in 2000 and is based in Jerusalem, Israel.

Hot Stocks To Watch:

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE